These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 25144875)

  • 21. Cholesterol, synaptic function and Alzheimer's disease.
    Koudinov AR; Koudinova NV
    Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S107-12. PubMed ID: 14574623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein receptor 2 and X11 alpha/beta mediate apolipoprotein E-induced endocytosis of amyloid-beta precursor protein and beta-secretase, leading to amyloid-beta production.
    He X; Cooley K; Chung CH; Dashti N; Tang J
    J Neurosci; 2007 Apr; 27(15):4052-60. PubMed ID: 17428983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteoglycans in the central nervous system: role in development, neural repair, and Alzheimer's disease.
    Cui H; Freeman C; Jacobson GA; Small DH
    IUBMB Life; 2013 Feb; 65(2):108-20. PubMed ID: 23297096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocytic mechanisms and drug discovery in neurodegenerative diseases.
    Zhang M
    Front Biosci; 2008 May; 13():6086-105. PubMed ID: 18508646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies.
    Hashimoto M; Masliah E
    Neurochem Res; 2003 Nov; 28(11):1743-56. PubMed ID: 14584828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Full-length amyloid precursor protein regulates lipoprotein metabolism and amyloid-β clearance in human astrocytes.
    Fong LK; Yang MM; Dos Santos Chaves R; Reyna SM; Langness VF; Woodruff G; Roberts EA; Young JE; Goldstein LSB
    J Biol Chem; 2018 Jul; 293(29):11341-11357. PubMed ID: 29858247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation and function of apolipoprotein E-containing lipoproteins in the nervous system.
    Vance JE; Hayashi H
    Biochim Biophys Acta; 2010 Aug; 1801(8):806-18. PubMed ID: 20170744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease.
    Poirier J
    Trends Mol Med; 2003 Mar; 9(3):94-101. PubMed ID: 12657430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease.
    Dorey E; Chang N; Liu QY; Yang Z; Zhang W
    Neurosci Bull; 2014 Apr; 30(2):317-30. PubMed ID: 24652457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pathological cross talk between apolipoprotein E and amyloid-beta peptide in Alzheimer's disease: emerging gene-based therapeutic approaches.
    Iurescia S; Fioretti D; Mangialasche F; Rinaldi M
    J Alzheimers Dis; 2010; 21(1):35-48. PubMed ID: 20182014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1.
    Liu Q; Zerbinatti CV; Zhang J; Hoe HS; Wang B; Cole SL; Herz J; Muglia L; Bu G
    Neuron; 2007 Oct; 56(1):66-78. PubMed ID: 17920016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholesterol metabolism, apolipoprotein E, adenosine triphosphate-binding cassette transporters, and Alzheimer's disease.
    Hirsch-Reinshagen V; Wellington CL
    Curr Opin Lipidol; 2007 Jun; 18(3):325-32. PubMed ID: 17495608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The involvement of lipids in Alzheimer's disease.
    Lim WL; Martins IJ; Martins RN
    J Genet Genomics; 2014 May; 41(5):261-74. PubMed ID: 24894353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier.
    Deane R; Wu Z; Zlokovic BV
    Stroke; 2004 Nov; 35(11 Suppl 1):2628-31. PubMed ID: 15459432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease.
    Christie RH; Chung H; Rebeck GW; Strickland D; Hyman BT
    J Neuropathol Exp Neurol; 1996 Apr; 55(4):491-8. PubMed ID: 8786409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition.
    Liu CC; Hu J; Zhao N; Wang J; Wang N; Cirrito JR; Kanekiyo T; Holtzman DM; Bu G
    J Neurosci; 2017 Apr; 37(15):4023-4031. PubMed ID: 28275161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies.
    Hölscher C
    Rev Neurosci; 2005; 16(3):181-212. PubMed ID: 16323560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model.
    Katsouri L; Georgopoulos S
    PLoS One; 2011; 6(7):e21880. PubMed ID: 21755005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A death receptor 6-amyloid precursor protein pathway regulates synapse density in the mature CNS but does not contribute to Alzheimer's disease-related pathophysiology in murine models.
    Kallop DY; Meilandt WJ; Gogineni A; Easley-Neal C; Wu T; Jubb AM; Yaylaoglu M; Shamloo M; Tessier-Lavigne M; Scearce-Levie K; Weimer RM
    J Neurosci; 2014 May; 34(19):6425-37. PubMed ID: 24806669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.